Subsequently, we injected Apt‐ or MSC‐EXOs into db/db mice via the tail vein and demonstrated that Apt conjugation strengthened the effects of MSC‐EXOs on diabetes‐induced muscle atrophy, providing a new idea to improve the efficacy of EXOs in the treatment of muscle diseases. This evidence concerns the gene LYPLA2P1 and muscle atrophy.